FDA Proposes Priorities For Cosmetic Ingredient Review Mica Probiotics CBD
FDA Proposes Priorities For Cosmetic Ingredient Review: Mica, Probiotics, CBD
11:09 EDT 18 Apr 2019 |
SCRIP
Nakissa Sadrieh, director of cosmetics at FDA and the agency’s CIR liaison, floated the three potential review priorities at the...
More From BioPortfolio on "FDA Proposes Priorities For Cosmetic Ingredient Review: Mica, Probiotics, CBD"